Current progress in the inflammatory background of angiogenesis in gynecological cancers.


Journal

Inflammation research : official journal of the European Histamine Research Society ... [et al.]
ISSN: 1420-908X
Titre abrégé: Inflamm Res
Pays: Switzerland
ID NLM: 9508160

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 17 04 2018
accepted: 14 01 2019
revised: 10 01 2019
pubmed: 27 1 2019
medline: 14 8 2019
entrez: 26 1 2019
Statut: ppublish

Résumé

A tumor growth depends on the potency of the tumor to support itself with nutrients and oxygen. The development of a vascular network within the tumor is key to its survival. The permanent contest between the tumor and its host involves tumor cells on one side and an immunological system and tissue stroma on the other. The angiogenesis is not only a specialty of the tumor, but it also depends on this complex multidirectional interaction. The most common gynecological cancers, cervical, endometrial and ovarian carcinoma are good examples for studying this problem. In this review, we aim to show that an inflammatory response against a tumor can be reverted into an undesirable process leading to the development of a vascular network within the tumor and, subsequently, further growth of the tumor and progression of a disease. Therefore, a key for tumor management should be searched within the immunological system, rather than focused on cell cycle and anti-angiogenic treatment only.

Identifiants

pubmed: 30680411
doi: 10.1007/s00011-019-01215-1
pii: 10.1007/s00011-019-01215-1
pmc: PMC6420455
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

247-260

Références

Genes Dev. 1999 Jun 1;13(11):1382-97
pubmed: 10364156
Cytokine. 1999 Sep;11(9):704-12
pubmed: 10479407
Int J Cancer. 1999 Oct 22;84(5):538-43
pubmed: 10502735
Cancer Res. 2000 Oct 1;60(19):5334-9
pubmed: 11034066
Immunol Rev. 2000 Oct;177:195-203
pubmed: 11138776
J Histochem Cytochem. 2001 Aug;49(8):1061-2
pubmed: 11457936
Anticancer Res. 2001 Jul-Aug;21(4B):2983-7
pubmed: 11712798
J Cell Mol Med. 2002 Jan-Mar;6(1):1-12
pubmed: 12003665
N Engl J Med. 2003 Jan 16;348(3):203-13
pubmed: 12529460
Am J Pathol. 2003 Oct;163(4):1233-43
pubmed: 14507633
J Exp Med. 2003 Nov 3;198(9):1391-402
pubmed: 14597738
Anticancer Res. 2003 Sep-Oct;23(5b):4261-7
pubmed: 14666636
J Biol Chem. 2004 May 28;279(22):23477-85
pubmed: 15026414
Gynecol Oncol. 2005 Oct;99(1):20-5
pubmed: 16055178
Int J Cancer. 2005 Dec 10;117(5):701-8
pubmed: 16106399
Cancer Res. 2005 Oct 1;65(19):8896-904
pubmed: 16204061
Clin Cancer Res. 2005 Oct 15;11(20):7243-54
pubmed: 16243794
Am J Obstet Gynecol. 2005 Dec;193(6):1961-5
pubmed: 16325597
Cancer Res. 2006 Jan 15;66(2):605-12
pubmed: 16423985
J Clin Invest. 2006 Mar;116(3):753-9
pubmed: 16470245
J Natl Cancer Inst. 1990 Jan 3;82(1):4-6
pubmed: 1688381
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12493-8
pubmed: 16891410
Gynecol Oncol. 2006 Dec;103(3):831-40
pubmed: 16919315
Matrix Biol. 2007 Jan;26(1):58-68
pubmed: 17055233
Curr Top Dev Biol. 2006;76:217-57
pubmed: 17118268
Clin Oncol (R Coll Radiol). 2007 Mar;19(2):154-61
pubmed: 17355113
Blood. 2007 Jul 15;110(2):587-95
pubmed: 17395778
Angiogenesis. 2007;10(3):149-66
pubmed: 17457680
Trends Immunol. 2007 Aug;28(8):360-5
pubmed: 17625970
J Thromb Haemost. 2007 Jul;5 Suppl 1:32-40
pubmed: 17635706
Nature. 2007 Dec 6;450(7171):825-31
pubmed: 18064003
Gynecol Oncol. 2008 Apr;109(1):122-8
pubmed: 18289648
J Pharmacol Sci. 2008 Feb;106(2):208-18
pubmed: 18296861
BMC Med. 2008 Apr 28;6:11
pubmed: 18442412
J Exp Med. 2008 Jun 9;205(6):1261-8
pubmed: 18490490
Gynecol Oncol. 2008 Aug;110(2):216-21
pubmed: 18533240
Nature. 2008 Jul 24;454(7203):436-44
pubmed: 18650914
Cancer Sci. 2008 Aug;99(8):1501-6
pubmed: 18754859
Cancer Res. 2008 Sep 1;68(17):7090-9
pubmed: 18757424
Clin Cancer Res. 2008 Nov 1;14(21):6735-41
pubmed: 18980965
Gynecol Oncol. 2009 Jan;112(1):229-34
pubmed: 19007976
Cancer Sci. 2008 Oct;99(10):1901-7
pubmed: 19016748
Surgery. 2009 Jan;145(1):57-68
pubmed: 19081476
Am J Pathol. 2009 Mar;174(3):1027-36
pubmed: 19218337
Angiogenesis. 2009;12(2):165-75
pubmed: 19219555
J Allergy Clin Immunol. 2009 May;123(5):1142-9, 1149.e1-5
pubmed: 19275959
Clin Cancer Res. 2009 Apr 15;15(8):2675-84
pubmed: 19336519
BMC Cancer. 2009 May 12;9:143
pubmed: 19435493
Aust N Z J Obstet Gynaecol. 2009 Aug;49(4):434-8
pubmed: 19694703
Cancer Cell. 2009 Sep 8;16(3):183-94
pubmed: 19732719
Neoplasia. 2009 Nov;11(11):1235-42
pubmed: 19881959
Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):483-90
pubmed: 20042707
J Natl Cancer Inst. 2010 Apr 21;102(8):522-8
pubmed: 20233997
J Immunol. 2010 May 1;184(9):5232-41
pubmed: 20357262
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Allergy. 2010 Aug;65(8):946-58
pubmed: 20415716
J Immunol. 2010 Jul 1;185(1):642-52
pubmed: 20530259
Cancer Res. 2010 Jul 15;70(14):5728-39
pubmed: 20570887
Exp Mol Pathol. 2010 Oct;89(2):190-6
pubmed: 20599941
Cancer Lett. 2010 Oct 28;296(2):144-9
pubmed: 20633984
PLoS One. 2010 Aug 23;5(8):e12360
pubmed: 20808808
Cancer Res. 2010 Sep 15;70(18):7073-83
pubmed: 20823158
Am J Reprod Immunol. 2011 Apr;65(4):438-47
pubmed: 20825380
Nat Immunol. 2010 Oct;11(10):889-96
pubmed: 20856220
BMC Cancer. 2010 Sep 27;10:512
pubmed: 20875124
Blood. 2011 Jan 6;117(1):323-32
pubmed: 20952691
Asian Pac J Cancer Prev. 2010;11(3):623-6
pubmed: 21039027
Eur J Immunol. 2011 Feb;41(2):306-12
pubmed: 21268001
Nature. 2011 Jun 08;475(7355):222-5
pubmed: 21654748
PLoS One. 2011;6(6):e20705
pubmed: 21695196
Nat Rev Immunol. 2011 Jul 25;11(8):519-31
pubmed: 21785456
Crit Rev Oncol Hematol. 2012 Jun;82(3):296-309
pubmed: 21798756
PLoS Biol. 2011 Sep;9(9):e1001162
pubmed: 21980263
J Obstet Gynaecol Res. 2012 Jan;38(1):57-64
pubmed: 22136730
J Biol Chem. 2012 Mar 2;287(10):7190-202
pubmed: 22247553
PLoS One. 2012;7(2):e31524
pubmed: 22348096
Carcinogenesis. 2012 May;33(5):949-55
pubmed: 22425643
J Biol Chem. 2012 Jun 1;287(23):19574-84
pubmed: 22528488
Cold Spring Harb Perspect Med. 2012 May;2(5):a006627
pubmed: 22553494
Cytokine. 2012 Aug;59(2):417-22
pubmed: 22626766
Mol Oncol. 2013 Feb;7(1):41-54
pubmed: 22944067
Am J Pathol. 2012 Dec;181(6):1895-9
pubmed: 23063657
J Obstet Gynaecol Res. 2013 Apr;39(4):855-63
pubmed: 23106983
PLoS One. 2013;8(1):e54916
pubmed: 23372791
Semin Cancer Biol. 2013 Jun;23(3):149-58
pubmed: 23410638
Br J Cancer. 2013 May 28;108(10):2116-22
pubmed: 23591202
Oncogene. 2014 May 1;33(18):2295-306
pubmed: 23728342
Matrix Biol. 2014 Apr;35:206-14
pubmed: 24060754
Cancer Immunol Immunother. 2013 Nov;62(11):1745-56
pubmed: 24092389
Clin Cancer Res. 2014 Feb 1;20(3):711-23
pubmed: 24218511
Anticancer Res. 2013 Nov;33(11):4785-90
pubmed: 24222114
Adv Clin Exp Med. 2013 Nov-Dec;22(6):839-45
pubmed: 24431313
J Ovarian Res. 2014 Feb 08;7:19
pubmed: 24507759
Dis Markers. 2014;2014:683757
pubmed: 24591765
J Immunol. 2014 Apr 15;192(8):3858-67
pubmed: 24639350
APMIS. 2014 Nov;122(11):1059-69
pubmed: 24698523
Cancer Cell. 2014 Jun 16;25(6):846-59
pubmed: 24898549
Immunity. 2014 Jul 17;41(1):49-61
pubmed: 25035953
Adv Cancer Res. 2014;123:191-209
pubmed: 25081530
Cancers (Basel). 2014 Aug 13;6(3):1670-90
pubmed: 25125485
J Clin Invest. 2014 Oct;124(10):4614-28
pubmed: 25202979
Ann Oncol. 2015 Aug;26(8):1698-704
pubmed: 25995301
PLoS One. 2015 Sep 03;10(9):e0136654
pubmed: 26335330
Sci Rep. 2015 Oct 14;5:15179
pubmed: 26462617
Cancer Res. 2015 Nov 15;75(22):4742-52
pubmed: 26471360
J Biol Chem. 2016 Feb 5;291(6):2731-50
pubmed: 26668310
Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):16000-5
pubmed: 26668367
PLoS One. 2016 Jan 26;11(1):e0147600
pubmed: 26811931
Eur J Cancer. 2016 Mar;56:131-143
pubmed: 26849037
Clin Exp Med. 2017 Feb;17(1):71-77
pubmed: 26886279
Int J Gynecol Cancer. 2016 May;26(4):671-9
pubmed: 26905331
Mediators Inflamm. 2016;2016:6058147
pubmed: 26966341
Wounds. 2016 Mar;28(3):78-88
pubmed: 26978861
Cell Immunol. 2016 Dec;310:42-52
pubmed: 27502363
Pharmacol Ther. 2016 Dec;168:61-74
pubmed: 27593890
Cell Death Dis. 2016 Sep 08;7(9):e2368
pubmed: 27607583
Oncotarget. 2016 Nov 15;7(46):75339-75352
pubmed: 27659538
Oncol Lett. 2016 Oct;12(4):2625-2631
pubmed: 27698836
Life Sci. 2017 Mar 1;172:27-41
pubmed: 27986539
Oncotarget. 2017 Feb 28;8(9):15621-15631
pubmed: 28152503
Cell Immunol. 2017 Jun;316:1-10
pubmed: 28433198
Front Immunol. 2017 Apr 12;8:424
pubmed: 28446910
Oncoimmunology. 2017 Jul 24;6(9):e1338230
pubmed: 28932636
Oncoimmunology. 2017 Aug 9;6(11):e1356148
pubmed: 29147608
Nutrients. 2018 Jan 15;10(1):null
pubmed: 29342940
Cell Immunol. 2018 Jan 30;:null
pubmed: 29395859
Cancer Lett. 2018 Sep 28;432:144-155
pubmed: 29879497
J Clin Invest. 1995 May;95(5):2391-6
pubmed: 7738202
Br J Cancer. 1996 Oct;74(7):999-1004
pubmed: 8855965
Blood. 1997 Nov 15;90(10):4153-61
pubmed: 9354686

Auteurs

Grzegorz Szewczyk (G)

Chair and Department of General and Experimental Pathology, Medical University of Warsaw, ul. Pawinskiego 3C, 02-106, Warsaw, Poland. grzegorz.szewczyk@wum.edu.pl.

Tomasz M Maciejewski (TM)

Department of Gynecology and Obstetrics, Institute of Mother and Child, ul. Kasprzaka 17A, 01-211, Warsaw, Poland.

Dariusz Szukiewicz (D)

Chair and Department of General and Experimental Pathology, Medical University of Warsaw, ul. Pawinskiego 3C, 02-106, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH